title: Hyperbaric oxygen treatment produces an antinociceptive response phase and inhibits astrocyte activation and inflammatory response in a rat model of neuropathic pain.
abstract: Hyperbaric oxygen (HBO) treatment has been proven to be a promising candidate for protection of the nervous system after acute injury in animal models of neuropathic pain. The purposes of this study were to examine the antinociceptive response phase induced by HBO treatment in a model of neuropathic pain and to determine the dependence of the treatment's mechanism of alleviating neuropathic pain on the inhibition of spinal astrocyte activation. Neuropathic pain was induced in rats by chronic constriction injury of the sciatic nerve. Mechanical threshold and thermal latency were tested preoperatively and for 1 week postoperatively, four times daily at fixed time points. Methane dicarboxylic aldehyde (MDA) and superoxide dismutase (SOD) parameters were used as indices of oxidative stress response and tested before and after the treatment. The inflammatory cytokines interleukin (IL)-1β and IL-10 were assayed in the sciatic nerve were with enzyme-linked immunoassay. Glial fibrillary acidic protein activation in the spinal cord was evaluated immunohistochemically. The rats exhibited temporary allodynia immediately after HBO treatment completion. This transient allodynia was closely associated with changes in MDA and SOD levels. A single HBO treatment caused a short-acting antinociceptive response phase. Repetitive HBO treatment led to a long-acting antinociceptive response phase and inhibited astrocyte activation. These results indicated that HBO treatment played a dual role in the aggravation and alleviation of neuropathic pain, though the aggravated pain effect (transient allodynia) was far less pronounced than the antinociceptive phase. Astrocyte inhibition and anti-inflammation may contribute to the antinociceptive effect of HBO treatment after nerve injury.
authors.affiliation: Department of Anesthesiology, China Medical University, Shengjing Hospital, 110004, Shenyang, China, zhaobaisong819@163.com.
authors.forename: Bai-Song
authors.initials: BS
authors.lastname: Zhao
authors.forename: Ling-Xin
authors.initials: LX
authors.lastname: Meng
authors.forename: Yuan-Yuan
authors.initials: YY
authors.lastname: Ding
authors.forename: Yan-Yan
authors.initials: YY
authors.lastname: Cao
mesh_terms: D000818:Animals; D001253:Astrocytes / Q000378:metabolism*; D005904:Glial Fibrillary Acidic Protein / Q000235:genetics / Q000378:metabolism; D006931:Hyperbaric Oxygenation; D007249:Inflammation / Q000378:metabolism / Q000628:therapy; D016753:Interleukin-10 / Q000235:genetics / Q000378:metabolism; D053583:Interleukin-1beta / Q000235:genetics / Q000378:metabolism; D008297:Male; D009437:Neuralgia / Q000378:metabolism / Q000628:therapy*; D059225:Nociception; D018384:Oxidative Stress; D051381:Rats; D017207:Rats, Sprague-Dawley; D012584:Sciatic Nerve / Q000293:injuries
chemical_list: D005904:Glial Fibrillary Acidic Protein; D053583:Interleukin-1beta; D016753:Interleukin-10